✦ LIBER ✦

6089 FOLFOX-4 versus FOLFIRI in the treatment of metastatic colorectal cancer–aprospective randomised study

✍ Scribed by Badulescu, F.; Badulescu, A.; Schenker, M.; Ionescu, M.; Ninulescu, C.; Crisan, A.; Dinescu, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FOLFOX4 in the treatment of metastatic c

✍ Massimiliano Berretta; Alessandro Cappellani; Francesco Fiorica; Guglielmo Nasti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Safety and efficacy of first-line bevaci

✍ Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolome 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 201 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

✍ Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Vehling-Kaiser, U.; Jage 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 225 KB

An observational study of bevacizumab co

✍ Huang, Meng-Lin; Kan, Jung-Yu; Ma, Cheng-Jen; Huang, Ching-Wen; Chen, Fang-Ming; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 261 KB

3046 POSTER A randomized, open-label pha

✍ T.E. Ciuleanu; W. Scheithauer; G. Kurteva; J. Ocvirk; I. Koza; D. Papamichael; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

10LBA Randomized phase 3 study of panitu

✍ J. Douillard; S. Siena; J. Cassidy; J. Tabernero; R. Burkes; M.E. Barugel; Y. Hu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB